Unite with XDEMVY^®

Join the XDEMVY Community!

Stay informed, receive support, and be empowered in your journey with Demodex blepharitis (DB).

(*Fields, questions, and check boxes marked with asterisks are required.)

Which best describes you?*

(Please make a selection.)

“I have been diagnosed with DB or suspect I have DB.”

“I am taking or have taken XDEMVY.”

Name*

Email*

Phone Number

Taken XDEMVY Date

Yes! Please contact me at this email address with additional information related to XDEMVY and Demodex blepharitis (DB).

By submitting, I confirm that I agree to the Terms of Use and Privacy Policy.*

By checking this box, I agree to receive promotional text messages. I understand that carrier rates may apply. I do not need to agree to receive SMS/text messages as a condition of signing up to receive information about XDEMVY and Demodex blepharitis (DB).

Browse Helpful Resources

Find resources to support your journey.

Browse Now

Xdemvy Success Stories

See the experiences of XDEMVY patients.

Meet XDEMVY Patients

Important Safety Information

Most common side effects: The most common side effect in clinical trials was stinging and burning in 10% of patients. Other side effects in less than 2% of patients were chalazion/hordeolum and punctate keratitis. 

Handling the Container: Avoid allowing the tip of the dispensing container to contact the eye, surrounding structures, fingers, or any other surface in order to minimize contamination of the solution. Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions.

When to Seek Physician Advice: Immediately seek a physician’s advice concerning the continued use of XDEMVY if you develop an intercurrent ocular condition (e.g., trauma or infection), have ocular surgery, or develop any ocular reactions, particularly conjunctivitis and eyelid reactions. 

Use with Contact Lenses: XDEMVY contains potassium sorbate, which may discolor soft contact lenses. Contact lenses should be removed prior to instillation of XDEMVY and may be reinserted 15 minutes following its administration.

To report SUSPECTED ADVERSE REACTIONS, contact Tarsus Pharmaceuticals at 1-888-421-4002 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

By prescription only.

Unite with XDEMVY®

Join the XDEMVY Community!

Browse Helpful Resources

Xdemvy Success Stories

You are leaving the XDEMVY® patient website and going to the Tarsus Pharmaceuticals, Inc. corporate website.

You are leaving the XDEMVY® patient website and going to the healthcare professional website.

You are leaving the XDEMVY® patient website.

Are you a US healthcare professional?

HAVE EYELID ISSUES?

Still have questions?

HAVE EYELID ISSUES?

Unite with XDEMVY^®

You are leaving the XDEMVY^® patient website and going to the Tarsus Pharmaceuticals, Inc. corporate website.

You are leaving the XDEMVY^® patient website and going to the healthcare professional website.

You are leaving the XDEMVY^® patient website.